How Private Equity Oversees the Ethics of Drug Research​

How Private Equity Oversees the Ethics of Drug Research​

RSS » New York Times News » NYTHealth

How Private Equity Oversees the Ethics of Drug Research​

October 6, 2025

INV-IRBs-mediumSquareAt3X-GikuTo-rss

 Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • Educational Resources
Breaking the Cycle: The Global Antimicrobial Resistance Crisis
Antimicrobial Resistance Crisis
  • One Health Insights
The Fine Line: Responsible Antibiotic Use in a Changing World
Responsible Antibiotic Use
  • One Health Insights
Hidden Exposure: Understanding Antibiotics in Our Food Chain
Antibiotics in Our Food Chain

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts